Innoviva (INVA) Misses Q1 EPS by 7c

Innoviva (NASDAQ: INVA) reported Q1 EPS of $0.19, $0.07 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $40.5 million versus the consensus estimate of $47.06 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.

You May Also Be Interested In

• Oppenheimer Assumes Inova Technology, Inc. (INVA) at Outperform
• Aytu BioScience (AYTU) Tops Q4 EPS by 28c
• Goldman Sachs Downgrades Bank Mandiri (BMRI:IJ) (PPERF) to Sell, 'Liquidity and capital tightness'